Source: Annual Congress 2011 - Bronchial hyperresponsiveness and exhaled and sputum biomarkers
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
S. Soodaeva, I. Klimanov, A. Lisitsa, E. Zaprudnova (Moscow, Vladimir, Russian Federation). The nitric oxide (NO) metabolites in monitoring and therapy of bronchial asthma. Eur Respir J 2011; 38: Suppl. 55, 4045

Member's Comments

No comment yet.

Related content which might interest you: Changes of exhaled nitric oxide during steroid treatment of childhood asthma Source: Eur Respir J 2002; 19: 1015-1019 Year: 2002 Exhaled nitric oxide (NO) detection for monitoring airway inflammation in non-severe CAP Source: Annual Congress 2008 - Diagnostic tests in lower respiratory tract infections Year: 2008 Increased nitric oxide production by neutrophils in bronchial asthma Source: Eur Respir J 2001; 17: 868-871 Year: 2001 Changes in nitric oxide production in patients with bronchial asthma Source: Eur Respir J 2007; 30: Suppl. 51, 588s Year: 2007 Features of production nitric oxide at patients with a bronchial asthma Source: Eur Respir J 2006; 28: Suppl. 50, 445s Year: 2006 Levels of asthma control and exhaled nitric oxide Source: Annual Congress 2009 - Airway inflammation and asthma control Year: 2009 Utility of fractional exhaled nitric oxide (FeNO) in assessing asthma control following inhaled corticosteroid treatment Source: International Congress 2016 – Assessing lower airway inflammation with different tools Year: 2016 An increase in exhaled nitric oxide is not associated with activity in pulmonary sarcoidosis Source: Eur Respir J 2004; 24 : 609-614 Year: 2004 Nasal nitric oxide Source: Eur Respir Monogr 2010; 49: 71-81 Year: 2010 Exhaled nitric oxide in asthma Source: Eur Respir Monogr 2010; 49: 32-44 Year: 2010 Differential assessment of airway inflammation and anti-inflammatory treatment in asthma by measurements of exhaled nitric oxide (NO) derived from peripheral versus central airways Source: Eur Respir J 2003; 22: Suppl. 45, 449s Year: 2003 Predicting response to corticosteroid in COPD using exhaled nitric oxide Source: Annual Congress 2009 - Drug effects in COPD Year: 2009 Exhaled nitric oxide (NO) in patients with chronic cough Source: Eur Respir J 2004; 24: Suppl. 48, 580s Year: 2004 Salbutamol temporarily increases the bronchial production of nitric oxide Source: Eur Respir J 2007; 30: Suppl. 51, 63s Year: 2007 Effect of montelukast added to inhaled corticosteroids on fractional exhaled nitric oxide in asthmatic children Source: Eur Respir J 2002; 20: 630-634 Year: 2002 Exhaled nitric oxide in the assessment of asthma control Source: Eur Respir J 2007; 30: Suppl. 51, 18s Year: 2007 Exhaled nitric oxide values measured at 10ml/s influence assessments of bronchial nitric oxide flux Source: Eur Respir J 2006; 28: Suppl. 50, 792s Year: 2006 Diagnosing asthma using exhaled nitric oxide (eNO) measurements Source: Annual Congress 2003 - Recognition, management and assessment of asthma including severe asthma Year: 2003 Airway and systemic nitric oxide pathway in COPD Source: International Congress 2019 – FeNO in airway diseases and asthma-COPD overlap identification Year: 2019 Changes in nitric oxide production in patients with COPD Source: Eur Respir J 2006; 28: Suppl. 50, 190s Year: 2006